CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population (Englisch)
- Neue Suche nach: He, N.
- Neue Suche nach: Yan, F.-X.
- Neue Suche nach: Huang, S.-L.
- Neue Suche nach: Wang, W.
- Neue Suche nach: Xiao, Z.-S.
- Neue Suche nach: Liu, Z.-Q.
- Neue Suche nach: Zhou, H.-H.
- Neue Suche nach: He, N.
- Neue Suche nach: Yan, F.-X.
- Neue Suche nach: Huang, S.-L.
- Neue Suche nach: Wang, W.
- Neue Suche nach: Xiao, Z.-S.
- Neue Suche nach: Liu, Z.-Q.
- Neue Suche nach: Zhou, H.-H.
In:
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
;
58
;
15-18
;
2002
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population
-
Beteiligte:He, N. ( Autor:in ) / Yan, F.-X. ( Autor:in ) / Huang, S.-L. ( Autor:in ) / Wang, W. ( Autor:in ) / Xiao, Z.-S. ( Autor:in ) / Liu, Z.-Q. ( Autor:in ) / Zhou, H.-H. ( Autor:in )
-
Erschienen in:EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY ; 58 ; 15-18
-
Verlag:
- Neue Suche nach: SPRINGER VERLAG KG
-
Erscheinungsdatum:01.01.2002
-
Format / Umfang:4 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 615.1 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 58
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
The effects of folate supplementation on some coagulation parameters and oxidative status surrogatesMayer, O. / Simon, J. / Rosolova, H. / Hromadka, M. / Subrt, I. / Vobrubova, I. et al. | 2002
- 7
-
No vasodilator response to low-dose heparin in the forearm skeletal-muscle vascular bedAbbink, E. J. / de Galan, B. E. / van Ginneken, E. E. / van Rosendaal, A. J. / Smits, P. et al. | 2002
- 11
-
Effect of a conserved mutation in uridine diphosphate glucuronosyltransferase 1A1 and 1A6 on glucuronidation of a metabolite of flutamideIto, M. / Yamamoto, K. / Maruo, Y. / Sato, H. / Fujiyama, Y. / Bamba, T. et al. | 2002
- 15
-
CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai populationHe, N. / Yan, F.-X. / Huang, S.-L. / Wang, W. / Xiao, Z.-S. / Liu, Z.-Q. / Zhou, H.-H. et al. | 2002
- 19
-
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxisThapar, M. M. / Ashton, M. / Lindegardh, N. / Bergqvist, Y. / Nivelius, S. / Johansson, I. / Bjorkman, A. et al. | 2002
- 29
-
Allele and genotype frequencies of polymorphic DCP1, CETP, ADRB2, and HTR2A in the Egyptian populationHamdy, S. I. / Hiratsuka, M. / Narahara, K. / El-Enany, M. / Moursi, N. / Ahmed, M. S.-E. / Mizugaki, M. et al. | 2002
- 37
-
Protein binding of ketamine and its active metabolites to human serumHijazi, Y. / Boulieu, R. et al. | 2002
- 41
-
Determination of thiopurine S-methyl-transferase phenotype using thin-layer chromatography and quantitative scanningDauer, M. / Schulze, J. / Loher, F. / Endres, S. / Eigler, A. et al. | 2002
- 45
-
Effects of grapefruit juice and smoking on verapamil concentrations in steady stateFuhr, U. / Muller-Peltzer, H. / Kem, R. / Lopez-Rojas, P. / Junemann, M. / Harder, S. / Staib, A. H. et al. | 2002
- 55
-
Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatmentPoluzzi, E. / Resi, D. / Zuccheri, P. / Motola, D. / De Ponti, F. / Vaccheri, A. / Montanaro, N. et al. | 2002
- 61
-
Use of unconventional medicine in Italy: a nation-wide surveyMenniti-Ippolito, F. / Gargiulo, L. / Bologna, E. / Forcella, E. / Raschetti, R. et al. | 2002
- 65
-
Knowledge on drug dosages of ward physiciansSchnurrer, J. U. / Stichtenoth, D. O. / Frolich, J. C. et al. | 2002
- 69
-
Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formationMiller, J. L. / Trepanier, L. A. et al. | 2002
- 73
-
The use of analgesic drugs in postoperative patients: the neglected problem of pain control in intensive care units. An observational, prospective, multicenter study in 128 Italian intensive care unitsBertolini, G. / Minelli, C. / Latronico, N. / Cattaneo, A. / Mura, G. / Melotti, R. M. / Iapichino, G. et al. | 2002
- 79
-
Availability of drugs to admitted patients in Yemeni public hospitalsStienstra, Y. / Muller, S. / van der Werf, T. S. / Abdo-Rabbo, A. / Haaijer-Ruskamp, F. M. et al. | 2002
- 85
-
Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetesFarker, K. / Merkel, U. / Schweer, H. / Haerting, J. / Madani, S. F. / Eggers, R. / Muller, U. A. / Seyberth, H. W. / Hoffmann, A. et al. | 2002
- 93
-
Inhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomesVietri, M. / Pietrabissa, A. / Mosca, F. / Pacifici, G. M. et al. | 2002
- 99
-
Hair analysis of flecainide for assessing the individual drug-taking behaviorTakiguchi, Y. / Ishihara, R. / Torii, M. / Kato, R. / Kamihara, S. / Uematsu, T. et al. | 2002
- 103
-
No evidence that amifostine influences the plasma pharmacokinetics of topotecan in ovarian cancer patientsZackrisson, A.-L. / Malmstrom, H. / Peterson, C. et al. | 2002
- 109
-
The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjectsJiang, Z.-P. / Shu, Y. / Chen, X.-P. / Huang, S.-L. / Zhu, R.-H. / Wang, W. / He, N. / Zhou, H.-H. et al. | 2002
- 115
-
N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinomaLadero, J. M. / Agundez, J. A. / Olivera, M. / Lozano, L. / Rodriguez-Lescure, A. / Diaz-Rubio, M. / Benitez, J. et al. | 2002
- 119
-
Dosage form-related food interaction observed in a marketed once-daily nifedpine formulation after a high-fat American breakfastSchug, B. S. / Brendel, E. / Wonnemann, M. / Wolf, D. / Wargenau, M. / Dingler, A. / Blume, H. H. et al. | 2002
- 127
-
Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trialSondergaard, J. / Andersen, M. / Vach, K. / Kragstrup, J. / Maclure, M. / Gram, L. F. et al. | 2002
- 133
-
Why has postal prescriber feedback no substantial impact on general practitioners' prescribing practice? A qualitative studySondergaard, J. / Andersen, M. / Kragstrup, J. / Hansen, H. P. / Gram, L. F. et al. | 2002
- 137
-
Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patientsLamminpaa, A. / Pukkala, E. / Teppo, L. / Neuvonen, P. J. et al. | 2002
- 143
-
Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderlyMovig, K. L. / Leufkens, H. G. / Lenderink, A. W. / Egberts, A. C. et al. | 2002
- 149
-
Incidence and determinants of migraine prophylactic medication in the NetherlandsRahimtoola, H. / Buurma, H. / Tijssen, C. C. / Leufkens, H. G. / Egberts, A. C. et al. | 2002
- 157
-
Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatmentvan de Vijver, D. A. / Roos, R. A. / Jansen, P. A. / Porsius, A. J. / de Boer, A. et al. | 2002
- 165
-
A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardiaBoriani, G. / Biffi, M. / Bacchi, L. / Martignani, C. / Zannoli, R. / Butrous, G. S. / Branzi, A. et al. | 2002
- 171
-
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthmaShioya, T. / Satake, M. / Sano, M. / Kagaya, M. / Watanabe, A. / Sato, K. / Ito, T. / Ito, N. / Sasaki, M. / Miura, M. et al. | 2002
- 177
-
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive menFogari, R. / Preti, P. / Derosa, G. / Marasi, G. / Zoppi, A. / Rinaldi, A. / Mugellini, A. et al. | 2002
- 181
-
Do cardiac glycosides affect platelet function? A flow cytometric study in healthy volunteersPettersen, E. / Hagberg, I. A. / Lyberg, T. / Gjesdal, K. et al. | 2002
- 187
-
5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonistsFowler, S. J. / Hall, I. P. / Wilson, A. M. / Wheatley, A. P. / Lipworth, B. J. et al. | 2002
- 191
-
Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthmaHarrison, L. I. / Kurup, S. / Chen, L.-Z. / Ekholm, B. P. / Wighton, T. G. / Shapiro, G. G. et al. | 2002
- 197
-
Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthmaHarrison, L. I. / Kurup, S. / Wagner, C. / Ekholm, B. P. / Larson, J. S. / Kaiser, H. B. et al. | 2002
- 203
-
Initiation of oral anticoagulant therapy in orthopedic and surgical patients: an algorithm compared with routine dosingvan den Bemt, P. M. / Beinema, M. / van Roon, E. N. / Sijtsma, J. / Baars, W. A. / Mencke, H. J. / Brouwers, J. R. et al. | 2002
- 209
-
Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm)Vlahovic-Palcevski, V. / Wettermark, B. / Bergman, U. et al. | 2002
- 215
-
Monitoring the variability in drug-prescribing patterns: benchmarking and feedback in BelgiumDelesie, L. / Croes, L. et al. | 2002
- 223
-
QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapyLLerena, A. / Berecz, R. / de la Rubia, A. / Dorado, P. et al. | 2002
- 227
-
Microdialysis: an in vivo approach for measuring drug delivery in oncologyBrunner, M. / Muller, M. et al. | 2002
- 235
-
Cimicifuga racemosa: a systematic review of its clinical efficacyBorrelli, F. / Ernst, E. et al. | 2002
- 243
-
Cyclosporin increases the exposure to tezosentan, an intravenous dual endothelin receptor antagonistvan Giersbergen, P. L. / Bodin, F. / Dingemanse, J. et al. | 2002
- 247
-
The pharmacokinetics of the antimigraine compound zolmitriptan In Japanese and Caucasian subjectsYates, P. A. / Tateno, M. / Nairn, K. / Ikegami, A. / Dane, A. / Kemp, J. et al. | 2002
- 253
-
Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approachMeyer-Barner, M. / Meineke, I. / Schreeb, K. H. / Gleiter, C. H. et al. | 2002
- 259
-
Effect of concomitant hormone replacement therapy containing estradiol and levonorgestrel on the pharmacokinetics of selegilinePalovaara, S. / Anttila, M. / Nyman, L. / Laine, K. et al. | 2002
- 265
-
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)Hedenmalm, K. / Spigset, O. et al. | 2002
- 275
-
A Swedish case-control network for studies of drug-induced morbidity - acute pancreatitisBlomgren, K. B. / Sundstrom, A. / Steineck, G. / Genell, S. / Sjostedt, S. / Wiholm, B.-E. et al. | 2002
- 285
-
Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based studySchneeweiss, S. / Hasford, J. / Gottler, M. / Hoffmann, A. / Riethling, A.-K. / Avorn, J. et al. | 2002
- 293
-
Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlandst Jong, G. W. / van der Linden, P. D. / Bakker, E. M. / van der Lely, N. / Eland, I. A. / Stricker, B. H. / van den Anker, J. N. et al. | 2002
- 299
-
Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-destiny lipoproteinOkuda, T. / Oh-i, T. et al. | 2002
- 303
-
Non-invasive assessment of selective 5-HT~1~B~/~1~D-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniquesVanmolkot, F. H. / de Hoon, J. N. / Barrington, P. / Peck, R. W. / Dallow, N. S. / Williams, P. M. / McColm, J. et al. | 2002
- 309
-
Comparative effects of tobacco smoking and nasal nicotineTeter, C. J. / Asfaw, B. / Ni, L. / Lutz, M. / Domino, E. F. / Guthrie, S. K. et al. | 2002
- 315
-
Effects of cigarette smoking on quinine pharmacokinetics in malariaPukrittayakamee, S. / Pitisuttithum, P. / Zhang, H. / Jantra, A. / Wanwimolruk, S. / White, N. J. et al. | 2002
- 321
-
Bacterial pneumonia can increase serum concentration of clozapineRaaska, K. / Raitasuo, V. / Arstila, M. / Neuvonen, P. J. et al. | 2002
- 323
-
Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variabilityGex-Fabry, M. / Rudaz, S. / Balant-Gorgia, A. E. / Brachet, A. / Veuthey, J.-L. / Balant, L. P. / Bertschy, G. et al. | 2002
- 333
-
Phenotypic polymorphism of CYP2A6 activity in a Chinese populationXu, P. / Huang, S.-L. / Zhu, R.-H. / Han, X.-M. / Zhou, H.-H. et al. | 2002
- 339
-
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malariaSvensson, U. S. / Alin, M. H. / Karlsson, M. O. / Bergqvist, Y. / Ashton, M. et al. | 2002
- 353
-
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1^*28 polymorphisms in cancer patients on chronic morphine therapyHolthe, M. / Klepstad, P. / Zahlsen, K. / Borchgrevink, P. C. / Hagen, L. / Dale, O. / Kaasa, S. / Krokan, H. E. / Skorpen, F. et al. | 2002
- 357
-
Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expressionSy, S. K. / Ciaccia, A. / Li, W. / Roberts, E. A. / Okey, A. / Kalow, W. / Tang, B.-K. et al. | 2002
- 367
-
Attitude of Czech physicians to adverse drug reaction reportingPerlik, F. / Slanar, O. / Smid, M. / Petracek, J. et al. | 2002
- 371
-
Adverse drug reactions and cognitive function among hospitalized older adultsOnder, G. / Gambassi, G. / Scales, C. J. / Cesari, M. / Vedova, C. D. / Landi, F. / Bernabe, R. et al. | 2002
- 379
-
Fluoxetine dose and outcome in antidepressant drug trialsBarbui, C. / Hotopf, M. / Garattini, S. et al. | 2002
- 387
-
Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofenDesjardins, P. / Black, P. / Papageorge, M. / Norwood, T. / Shen, D. D. / Norris, L. / Ardia, A. et al. | 2002
- 395
-
Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteersKienzler, J.-L. / Sallin, D. / Schifflers, M.-H. / Ghika, A. et al. | 2002
- 403
-
Effect of gender in the disposition of albendazole metabolites in humansMirfazaelian, A. / Dadashzadeh, S. / Rouini, M. R. et al. | 2002
- 409
-
Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute strokeStrid, S. / Borga, O. / Edenius, C. / Jostell, K.-G. / Odergren, T. / Weil, A. et al. | 2002
- 417
-
Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese populationHiratsuka, M. / Takekuma, Y. / Endo, N. / Narahara, K. / Hamdy, S. I. / Kishikawa, Y. / Matsuura, M. / Agatsuma, Y. / Inoue, T. / Mizugaki, M. et al. | 2002
- 423
-
Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjectsSpaans, E. / van den Heuvel, M. W. / Schnabel, P. G. / Peeters, P. A. / Chin-Kon-Sung, U. G. / Colbers, E. P. / Sitsen, J. M. et al. | 2002
- 431
-
Lithium carbonate as a potential pharmacological vehicle: intravenous kinetics of single-dose administration in healthy subjectsStephen Waring, W. / Webb, D. J. / Maxwell, S. R. et al. | 2002
- 435
-
Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosisIsabel Lucena, M. / Andrade, R. J. / Tognoni, G. / Hidalgo, R. / de la Cuesta, F. S. / Spanish Collaborative Study Group on Therapeutic Management in Liver Disease et al. | 2002
- 441
-
Neuropsychiatric events during prophylactic use of mefloquine before travellingvan Riemsdijk, M. M. / Ditters, J. M. / Sturkenboom, M. C. / Tulen, J. H. / Ligthelm, R. J. / Overbosch, D. / Stricker, B. H. et al. | 2002
- 447
-
New managing editorsDahlqvist, R. et al. | 2002
- 449
-
The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjectsLehtonen, L. / Sundberg, S. et al. | 2002
- 453
-
The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pHJunghard, O. / Hassan-Alin, M. / Hasselgren, G. et al. | 2002
- 459
-
Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheresRump, A. F. / Woschee, U. / Theisohn, M. / Fischbach, R. / Heindel, W. / Lackner, K. / Klaus, W. et al. | 2002
- 467
-
A simultaneous oral/intravenous population pharmacokinetic model for vinorelbineVariol, P. / Nguyen, L. / Tranchand, B. / Puozzo, C. et al. | 2002
- 477
-
Trends in consumption of calcium channel blockers in the Czech Republic during 1993-1999 and comparison with selected countries: drug utilization studyDolezal, T. / Nemecek, K. / Krsiak, M. et al. | 2002
- 479
-
Drug-related deaths in a university central hospitalJuntti-Patinen, L. / Neuvonen, P. J. et al. | 2002
- 483
-
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugsBate, A. / Lindquist, M. / Orre, R. / Edwards, I. R. / Meyboom, R. H. et al. | 2002
- 491
-
Effect of grapefruit juice intake on etoposide bioavailabilityReif, S. / Nicolson, M. C. / Bisset, D. / Reid, M. / Kloft, C. / Jaehde, U. / McLeod, H. L. et al. | 2002
- 495
-
Medicines for children licensed by the European Agency for the Evaluation of Medicinal ProductsCeci, A. / Felisi, M. / Catapano, M. / Baiardi, P. / Cipollina, L. / Ravera, S. / Bagnulo, S. / Reggio, S. / Rondini, G. et al. | 2002
- 501
-
The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemiaKoter, M. / Broncel, M. / Chojnowska-Jezierska, J. / Klikczynska, K. / Franiak, I. et al. | 2002
- 507
-
Population pharmacokinetics of cisapride in neonatesOdoul, F. / Le Guellec, C. / Henrot, A. / Saliba, E. / Levron, J. C. / Saux, M. C. / Paintaud, G. / Autret-Leca, E. et al. | 2002
- 515
-
Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteersChristensen, H. / Asberg, A. / Holmboe, A.-B. / Berg, K. J. et al. | 2002
- 521
-
Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignanciesKumana, C. R. / Au, W. Y. / Lee, N. S. / Kou, M. / Mak, R. W. / Lam, C. W. / Kwong, Y. L. et al. | 2002
- 527
-
The effect of fluconazole on the pharmacokinetics of rosuvastatinCooper, K. J. / Martin, P. D. / Dane, A. L. / Warwick, M. J. / Schneck, D. W. / Cantarini, M. V. et al. | 2002
- 533
-
CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish populationNiewinski, P. / Orzechowska-Juzwenko, K. / Hurkacz, M. / Rzemislawska, Z. / Jazwinska-Tarnawska, E. / Milejski, P. / Forkasiewicz, Z. et al. | 2002
- 537
-
Cytochrome P~4~6~0 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyre-sorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cellsBapiro, T. E. / Andersson, T. B. / Otter, C. / Hasler, J. A. / Masimirembwa, C. M. et al. | 2002
- 543
-
Polymorphic oxidative metabolism of proguanil in a Nigerian populationBolaji, O. O. / Sadare, I. O. / Babalola, C. P. / Ogunbona, F. A. et al. | 2002
- 547
-
Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001:change over timeWandell, P. E. / Gafvels, C. et al. | 2002
- 555
-
Analysis of CYP2C9^*5 in Caucasian, Oriental and Black-African populationsYasar, U. / Aklillu, E. / Canaparo, R. / Sandberg, M. / Sayi, J. / Roh, H.-K. / Wennerholm, A. et al. | 2002
- 559
-
Multivariate cluster analysis of a human hepatic cytochrome P~4~5~0 databaseSy, S. K. / Johnston, J. A. / Class, C. F. / Roberts, E. A. / Kalow, W. / Tang, B.-K. et al. | 2002
- 567
-
Quality of global e-pharmacies: can we safeguard consumers?Bessell, T. L. / Silagy, C. A. / Anderson, J. N. / Hiller, J. E. / Sansom, L. N. et al. | 2002
- 573
-
The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcomePignatti, F. / Aronsson, B. / Gate, N. / Vamvakas, S. / Wade, G. / Moulon, I. / Le Courtois, P. et al. | 2002
- 581
-
Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteersBauer, S. / Stormer, E. / Kerb, R. / Johne, A. / Brockmoller, J. / Roots, I. et al. | 2002
- 587
-
Therapeutic drug monitoring data: risperidone does not increase serum clozapine concentrationRaaska, K. / Raitasuo, V. / Neuvonen, P. J. et al. | 2002
- 593
-
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportBocci, G. / Danesi, R. / Allegrini, G. / Innocenti, F. / Di Paolo, A. / Falcone, A. / Conte, P. F. / Del Tacca, M. et al. | 2002
- 597
-
Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimusStaatz, C. E. / Tett, S. E. et al. | 2002
- 607
-
Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitusMarques, M. P. / Coelho, E. B. / Dos Santos, N. A. / Geleilete, T. J. / Lanchote, V. L. et al. | 2002
- 615
-
`In vitro' binding of propofol to serum lipoproteins in thyroid dysfunctionde la Fuente, L. / Lukas, J. C. / Vazquez, J. A. / Jauregizar, N. / Calvo, R. / Suarez, E. et al. | 2002
- 621
-
Age- and gender-related differences in carbohydrate concentrations of alpha~1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacitiesKishino, S. / Nomura, A. / Itoh, S. / Nakagawa, T. / Takekuma, Y. / Sugawara, M. / Furukawa, H. / Todo, S. / Miyazaki, K. et al. | 2002
- 629
-
Expressing effects of osteoporosis interventions in terms of postponing of fracturesChristensen, P. M. / Brosen, K. / Brixen, K. / Kristiansen, I. S. et al. | 2002
- 635
-
Towards a core curriculum in clinical pharmacology for undergraduate medical students in EuropeOrme, M. / Frolich, J. / Vrhovac, B. et al. | 2002
- 641
-
General adverse reaction to aspirin administered by transdermal iontophoresisMacchia, L. / Caiaffa, M. F. / Vacca, A. / Tursi, A. et al. | 2002
- 643
-
The skin vasoconstrictor assay does not correlate significantly to airway or systemic responsiveness to inhaled budesonide in asthmatic patientsWilson, A. M. / Coutie, W. J. / Sims, E. J. / Lipworth, B. J. et al. | 2003
- 649
-
Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malariaBarennes, H. / Sterlingot, H. / Nagot, N. / Meda, H. / Kabore, M. / Sanou, M. / Nacro, B. / Bouree, P. / Pussard, E. et al. | 2003
- 653
-
Effect of ciprofloxacin on the pharmacokinetics of ropivacaineJokinen, M. J. / Olkkola, K. T. / Ahonen, J. / Neuvonen, P. J. et al. | 2003
- 659
-
CYP2D6^*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjectsOhara, K. / Tanabu, S. / Ishibashi, K. / Ikemoto, K. / Yoshida, K. / Shibuya, H. et al. | 2003
- 663
-
Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peelWangensteen, H. / Molden, E. / Christensen, H. / Malterud, K. E. et al. | 2003
- 669
-
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentSimonson, S. G. / Martin, P. D. / Mitchell, P. / Schneck, D. W. / Lasseter, K. C. / Warwick, M. J. et al. | 2003
- 677
-
Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivoMyllynen, P. K. / Pienimaki, P. K. / Vahakangas, K. H. et al. | 2003
- 683
-
A clinical study investigating the pharmaco-kinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrateZdravkovic, M. / Olsen, A. K. / Christiansen, T. / Schulz, R. / Taub, M. E. / Thomsen, M. S. / Rasmussen, M. H. / Ilondo, M. M. et al. | 2003
- 689
-
Initial 3-month usage characteristics predict long-term use of benzodiazepines: and 8-year follow-upvan Hulten, R. / Teeuw, K. B. / Bakker, A. / Leufkens, H. G. et al. | 2003
- 695
-
Use of calcium antagonists and worsening renal function in patients receiving angiotensin-converting-enzyme inhibitorsZuccala, G. / Onder, G. / Pedone, C. / Cesari, M. / Marzetti, E. / Cocchi, A. / Carbonin, P. / Bernabei, R. et al. | 2003
- 701
-
Determinants for drug prescribing to children below the minimum licensed aget Jong, G. W. / Eland, I. A. / Sturkenboom, M. C. / van den Anker, J. N. / Stricker, B. H. et al. | 2003
- 707
-
Reporting adverse drug reactions on a geriatric ward: a pilot projectSomers, A. / Petrovic, M. / Robays, H. / Bogaert, M. et al. | 2003
- 715
-
Low plasma cefaclor levels in cystectomized bladder cancer patients with various types of urinary diversionMattioli, F. / Tognoni, P. / Corbu, C. / Martelli, A. et al. | 2003
- 717
-
Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserodBertoli, R. / Girardin, F. / Russmann, S. / Lauterburg, B. H. et al. | 2003
- 719
-
Beyond lipid-lowering: effects of statins on endothelial nitric oxideLaufs, U. et al. | 2003
- 733
-
Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy menDubois, E. F. / Derks, M. G. / Zwinderman, A. H. / Dekhuijzen, P. N. / Boxtel, C. J. / Schweitzer, D. H. et al. | 2003
- 739
-
Genetic and environmental risk factors for oral anticoagulant overdoseVerstuyft, C. / Robert, A. / Morin, S. / Loriot, M. A. / Flahault, A. / Beaune, P. / Funck-Brentano, C. / Jaillon, P. / Becquemont, L. et al. | 2003
- 747
-
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/ pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trialHornestam, B. / Jerling, M. / Karlsson, M. O. / Held, P. / DAAF Trail Group et al. | 2003
- 757
-
Short-acting parenteral antipsychotics drive choice for classical versus atypical agentsHugenholtz, G. W. / Stolker, J. J. / Heerdink, E. R. / Nolen, W. A. / Leufkens, H. G. et al. | 2003
- 761
-
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban AustraliaCutts, C. / Tett, S. E. et al. | 2003
- 767
-
Risk of drug-induced agranulocytosis: the case of calcium dobesilateZapater, P. / Horga, J. F. / Garcia, A. et al. | 2003
- 773
-
Potential drug-drug interactions in the medication of medical patients at hospital dischargeEgger, S. S. / Drewe, J. / Schlienger, R. G. et al. | 2003
- 779
-
Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in StockholmUfer, M. / Rane, A. / Karlsson, A. / Kimland, E. / Bergman, U. et al. | 2003
- 785
-
Codeine and clinical impairment in samples in which morphine is not detectedBachs, L. / Skurtveit, S. / Morland, J. et al. | 2003
- 791
-
Differences in flurbiprofen pharmaco-kinetics between CYP2C9^*1/^*1, ^*1/^*2, and ^*1/^*3 genotypesLee, C. R. / Pieper, J. A. / Frye, R. F. / Hinderliter, A. L. / Blaisdell, J. A. / Goldstein, J. A. et al. | 2003
- 795
-
Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjectsHermann, R. / Knebel, N. G. / Niebch, G. / Richards, L. / Borlak, J. / Locher, M. et al. | 2003
- 803
-
Diosmin pretreatment affects bioavailability of metronidazoleRajnarayana, K. / Reddy, M. S. / Krishna, D. R. et al. | 2003
- 809
-
Digoxin pharmacokinetics and MDR1 genetic polymorphismsVerstuyft, C. / Schwab, M. / Schaeffeler, E. / Kerb, R. / Brinkmann, U. / Jaillon, P. / Funck-Brentano, C. / Becquemont, L. et al. | 2003
- 813
-
Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC~0~-~1~2 monitoring in cardiac transplant recipients over the first year post-transplantationMonchaud, C. / Rousseau, A. / Leger, F. / David, O. J. / Debord, J. / Dantoine, T. / Marquet, P. et al. | 2003
- 821
-
Awareness of the side effects of possessed medications in a community settingPapanikolaou, P. N. / Ioannidis, J. P. et al. | 2003
- 829
-
Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated allelesSuzuki, Y. / Shioiri, T. / Muratake, T. / Kawashima, Y. / Sato, S. / Hagiwara, M. / Inoue, Y. / Shimoda, K. / Someya, T. et al. | 2003
- 835
-
Under-prescribing of cardiovascular therapies for diabetes in primary careBennett, K. E. / Williams, D. / Feely, J. et al. | 2003
- 843
-
Problems in collecting comparable national drug use data in Europe: the example of antibacterialsRonning, M. / Blix, H. S. / Strom, H. / Skovlund, E. / Andersen, M. / Stichele, R. V. et al. | 2003
- 851
-
Trends in prescribing antihypertensive drugs in the Gruppo Italiano di Farmacovigilanza nell'Anziano 1988-1997Incalzi, R. A. / Corsonello, A. / Pedone, C. / Corica, F. / Mazzei, B. / Perticone, F. / Carbonin, P. et al. | 2003